vs
Side-by-side financial comparison of AIRO Group Holdings, Inc. (AIRO) and Cellectis S.A. (CLLS). Click either name above to swap in a different company.
Cellectis S.A. is the larger business by last-quarter revenue ($9.5M vs $6.3M, roughly 1.5× AIRO Group Holdings, Inc.). AIRO Group Holdings, Inc. runs the higher net margin — -126.7% vs -265.9%, a 139.2% gap on every dollar of revenue. Cellectis S.A. produced more free cash flow last quarter ($27.6M vs $-6.7M).
Airo Aviation FZ-LLC was an Emirati aircraft manufacturer based in the Ras Al Khaimah Free Trade Zone. The company specialized in the manufacture of ultralight aircraft in the form of ready-to-fly aircraft for the European Fédération Aéronautique Internationale microlight category.
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.
AIRO vs CLLS — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2024
| Metric | | |
|---|---|---|
| Revenue | $6.3M | $9.5M |
| Net Profit | $-8.0M | $-25.3M |
| Gross Margin | 44.4% | — |
| Operating Margin | -190.7% | -181.1% |
| Net Margin | -126.7% | -265.9% |
| Revenue YoY | — | 375.0% |
| Net Profit YoY | — | -51.9% |
| EPS (diluted) | $-0.28 | $-0.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $6.3M | — | ||
| Q2 25 | $24.6M | — | ||
| Q2 24 | — | $9.5M | ||
| Q3 23 | — | $1.6M | ||
| Q2 23 | — | $2.0M | ||
| Q2 22 | — | $2.7M |
| Q3 25 | $-8.0M | — | ||
| Q2 25 | $5.9M | — | ||
| Q2 24 | — | $-25.3M | ||
| Q3 23 | — | $-17.5M | ||
| Q2 23 | — | $-16.6M | ||
| Q2 22 | — | $-19.5M |
| Q3 25 | 44.4% | — | ||
| Q2 25 | 61.2% | — | ||
| Q2 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | 97.3% | ||
| Q2 22 | — | 87.9% |
| Q3 25 | -190.7% | — | ||
| Q2 25 | -80.2% | — | ||
| Q2 24 | — | -181.1% | ||
| Q3 23 | — | -1258.1% | ||
| Q2 23 | — | -1180.5% | ||
| Q2 22 | — | -1003.0% |
| Q3 25 | -126.7% | — | ||
| Q2 25 | 23.9% | — | ||
| Q2 24 | — | -265.9% | ||
| Q3 23 | — | -1064.1% | ||
| Q2 23 | — | -831.6% | ||
| Q2 22 | — | -714.4% |
| Q3 25 | $-0.28 | — | ||
| Q2 25 | $0.30 | — | ||
| Q2 24 | — | $-0.28 | ||
| Q3 23 | — | $-0.31 | ||
| Q2 23 | — | $-0.20 | ||
| Q2 22 | — | $-0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $149.0M |
| Total DebtLower is stronger | $5.1M | — |
| Stockholders' EquityBook value | $739.5M | $148.6M |
| Total Assets | $774.6M | $407.1M |
| Debt / EquityLower = less leverage | 0.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | $149.0M | ||
| Q3 23 | — | — | ||
| Q2 23 | — | $84.4M | ||
| Q2 22 | — | $129.4M |
| Q3 25 | $5.1M | — | ||
| Q2 25 | $8.9M | — | ||
| Q2 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q3 25 | $739.5M | — | ||
| Q2 25 | $679.6M | — | ||
| Q2 24 | — | $148.6M | ||
| Q3 23 | — | $76.1M | ||
| Q2 23 | — | $96.6M | ||
| Q2 22 | — | $180.5M |
| Q3 25 | $774.6M | — | ||
| Q2 25 | $747.8M | — | ||
| Q2 24 | — | $407.1M | ||
| Q3 23 | — | $209.7M | ||
| Q2 23 | — | $227.7M | ||
| Q2 22 | — | $320.9M |
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q2 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.8M | $28.9M |
| Free Cash FlowOCF − Capex | $-6.7M | $27.6M |
| FCF MarginFCF / Revenue | -106.7% | 290.5% |
| Capex IntensityCapex / Revenue | 15.0% | 13.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-5.8M | — | ||
| Q2 25 | $-30.8M | — | ||
| Q2 24 | — | $28.9M | ||
| Q3 23 | — | — | ||
| Q2 23 | — | $-47.4M | ||
| Q2 22 | — | $-60.2M |
| Q3 25 | $-6.7M | — | ||
| Q2 25 | $-31.8M | — | ||
| Q2 24 | — | $27.6M | ||
| Q3 23 | — | — | ||
| Q2 23 | — | $-47.9M | ||
| Q2 22 | — | $-61.7M |
| Q3 25 | -106.7% | — | ||
| Q2 25 | -129.6% | — | ||
| Q2 24 | — | 290.5% | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -2391.4% | ||
| Q2 22 | — | -2266.7% |
| Q3 25 | 15.0% | — | ||
| Q2 25 | 4.3% | — | ||
| Q2 24 | — | 13.2% | ||
| Q3 23 | — | — | ||
| Q2 23 | — | 24.1% | ||
| Q2 22 | — | 56.6% |
| Q3 25 | — | — | ||
| Q2 25 | -5.24× | — | ||
| Q2 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIRO
| Transferred At Point In Time | $4.5M | 71% |
| Transferred Over Time | $1.8M | 29% |
CLLS
Segment breakdown not available.
